Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Caffeine citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for caffeine citrate and what is the scope of freedom to operate?

Caffeine citrate
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Sagent Pharms, Exela Pharma Scs Llc, Luitpold, Aurobindo Pharma Ltd, Exela Pharma Science, Sun Pharma Global, and West-ward Pharms Int, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for caffeine citrate. Eight suppliers are listed for this compound.

Summary for Generic Name: caffeine citrate

Drug Master File Entries: see list11
Suppliers / Packagers: see list8
Bulk Api Vendors: see list15
Clinical Trials: see list320
Patent Applications: see list184
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:caffeine citrate at DailyMed

Pharmacology for Ingredient: caffeine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
caffeine citrate
SOLUTION;ORAL020793-002Apr 12, 2000AARXYesYes► Subscribe► Subscribe
Exela Pharma Science
caffeine citrate
SOLUTION;INTRAVENOUS077233-001Sep 21, 2006APRXNoNo► Subscribe► Subscribe
caffeine citrate
SOLUTION;ORAL090064-001Nov 20, 2009AARXNoNo► Subscribe► Subscribe
Sun Pharma Global
caffeine citrate
SOLUTION;INTRAVENOUS090077-001Sep 30, 2009APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
caffeine citrate
SOLUTION;ORAL078002-001Jan 31, 2008AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus